Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri.
Corresponding author: Alexandra Rubin, MD, Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, MO; email: [email protected].
Financial Disclosure Ebony Carter disclosed that money was paid to her institution from the American Diabetes Association, NIH/NIMH, and the Robert Wood Johnson Foundation. She is part of and receives payment for Carter Expert and Strategic Consulting. Jeannie Kelly disclosed that money was paid to their institution from the PEW Charitable Trusts: Community Opioid Response and Evaluation (CORE) Project ID 00033770, the NICDH, Doris Duke, and the Barnes Jewish Foundation. The other authors did not report any potential conflicts of interest.
Presented at the American College of Obstetricians and Gynecologists’ Annual Clinical and Scientific Meeting, May 6–8, 2022, San Diego, California.
Funding for this project was supported by The PEW Charitable Trusts and the Community Opioid Response and Evaluation (CORE) Project (Grant ID: 00033770).
Dr. Carter, Associate Editor, Equity, of Obstetrics & Gynecology, was not involved in the review or decision to publish this article.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/C831.
